Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071480 · ClinicalTrials.gov registry record · NA
Noninvasive Therapy for Tinnitus
A NA study of Tinnitus and Tinnitus, Subjective, sponsored by Restorear Devices.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07071480 is a NA study of Tinnitus and Tinnitus, Subjective that is actively recruiting participants, run by Restorear Devices. The registered enrollment target is 40 participants, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07071480, a NA study of Tinnitus and Tinnitus, Subjective, is actively recruiting participants, sponsored by Restorear Devices.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional clinical study is to establish mild therapeutic hypothermia, delivered non-invasively to the structures of the inner ear, as a safe and repeatable therapeutic method for symptomatic relief of tinnitus. The study will assess both objective and subjective measures to address two main aims: 1. Ascertain the benefits of mild therapeutic hypothermia for symptomatic relief of chronic tinnitus in participants using the ReBound hypothermia device. 2. Ascertain the benefits of mild therapeutic hypothermia for symptom management in chronic tinnitus participants over six months using the ReBound device. Participants will wear the ReBound hypothermia device for 30 minutes in a single session. Researchers will compare results from those receiving the therapy to those from a control group (sham therapy). Participants will also use the device in-home for 6 months and monitor their symptoms with online surveys.
Conditions Studied
Interventions
- DEVICE Cold pack-delivered mild therapeutic hypothermia
- DEVICE Sham device
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07071480
The ClinicalTrials.gov registry entry for NCT07071480 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is Restorear Devices, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which Cold pack-delivered mild therapeutic hypothermia is the first listed.
NCT07071480 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07071480 about?
NCT07071480 is a clinical study titled "Noninvasive Therapy for Tinnitus". The goal of this interventional clinical study is to establish mild therapeutic hypothermia, delivered non-invasively to the structures of the inner ear, as a safe and repeatable therapeutic method for symptomatic relief of tinnitus. The study will assess both objective and subjective measures to ad...
What is the current status of trial NCT07071480?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-24. Estimated completion is 2027-05-31.
What conditions does trial NCT07071480 study?
This clinical trial studies the following conditions: Tinnitus, Tinnitus, Subjective.
What interventions are being tested in trial NCT07071480?
The interventions under investigation include: Cold pack-delivered mild therapeutic hypothermia (DEVICE), Sham device (DEVICE).
Who is sponsoring clinical trial NCT07071480?
This trial is sponsored by Restorear Devices, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071480 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
External Therapy for Tinnitus Management
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
-
Notched Noise Therapy for Suppression of Tinnitus
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.